HOME >> MEDICINE >> NEWS
Aventis Pasteur ready to meet nation's needs for tetanus and diphtheria vaccine

Swiftwater, PA June 20, 2002 Aventis Pasteur announced today that it has produced a sufficient supply of the adult and adolescent vaccine for tetanus and diphtheria, Tetanus and Diphtheria Toxoids Adsorbed For Adult Use (Td), to meet the nation's critical care and routine booster needs. According to the June 21, 2002, issue of the U.S. Centers for Disease Control and Prevention's (CDC) Morbidity & Mortality Weekly Report (MMWR), this increase in supply has prompted the CDC to lift its year-long deferral, enabling physicians to now provide patients with routine Td boosters.

"Aventis Pasteur has been working for the past year to successfully end the national shortage of Td vaccine," said Michael Decker, MD, MPH, vice president, scientific and medical affairs at Aventis Pasteur. "Aventis Pasteur's efforts to relieve the shortage is an indication of the company's ability to meet the nation's need for Td vaccine now and in the future."

"With the return of ample tetanus and diphtheria vaccine supply, people who were asked to delay Td boosters during the last year should schedule appointments with their doctors to catch up," said William Schaffner, MD, professor and chairman, department of preventive medicine at Vanderbilt University and a national expert in infectious diseases. "Furthermore, anyone who can't remember the last time they received a Td booster should call their doctor and ask if they are due to receive a booster."

Immunization is the best way to protect against tetanus and diphtheria infection in the United States since both diseases are vaccine-preventable. Adults and adolescents require a booster shot every 10 years throughout life to maintain protection against tetanus and diptheria. Almost all reported cases of tetanus are in persons who have either never been vaccinated, or who completed a primary series, but have not had a booster in the preceeding 10 years . A recent study showed that less than half of Americans 20 years
'"/>

Contact: Len Lavenda/Taryn Green
TGreen@cwg.com
212-886-2200
Cooney Waters Group, Inc.
20-Jun-2002


Page: 1 2

Related medicine news :

1. Aventis Pasteur donates approximately 75 to 90 million doses of smallpox vaccine to the U.S.
2. Aventis Pasteur statement on HVTN 501 decision
3. Millennium, Aventis Pharma form novel alliance
4. Aventis Pharmaceuticals Allegra (Fexofenadine Hcl) 30-Mg tablets now available to treat seasonal allergies, chronic hives in children 6 to 11 years
5. Get ready for next generation surround sound
6. Most physicians willing to serve but unready for bioterrorism
7. Surface treatments could make ready-to-eat products safer
8. Growth hormone, sex steroid combination not ready for prime time
9. Amid food safety concerns, K-State professor believes consumers ready for irradiated meat products
10. USC study shows teens with type 1 diabetes already face clogging arteries
11. Children remain alert and ready to learn when taking over-the-counter antihistamines that make adults drowsy

Post Your Comments:
(Date:5/21/2013)... funding agency for scientific and technological research So Paulo ... Paulo, announced an investment estimated in US$ 680 million ... for a period of up to eleven years, subject ... , Funding for the 17 RIDCs will come ... technicians, support personnel, and infrastructure). Host institutions will participate ...
(Date:5/21/2013)... Today, Zane Benefits, Inc. published a ... accounts. Zane Benefits, which provides comprehensive and flexible alternatives ... in defined contribution and http://HRA ... to Zane Benefits’ website, the Affordable Care Act (known ... in 2010 and impacts many areas of health care ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 While North ... synonymous with comprehensive travel guides. Brunswick Plantation & Golf ... packages that include access to 27 holes of "Top10" ... courses in North Carolina, knowing the Top 10 ... Lodges takes away the overwhelming task of selecting the ...
(Date:5/21/2013)... , , TUESDAY, May 21 (HealthDay News) -- Less is ... having severe bouts of chronic obstructive pulmonary disease (COPD), ... treatment with prednisone to treat COPD flare-ups was as ... chances for adverse side effects, they said. "We ... was not less effective than 14 days," said lead ...
(Date:5/21/2013)... ATS 2013, PHILADELPHIA ─ A study of veterans at ... computed tomography (LDCT) can be highly effective in helping ... number of patients, may indicate the earliest stages of ... the radiation of a conventional CT scan. , Results ... 2013 International Conference. , "Lung cancer is the leading ...
Breaking Medicine News(10 mins):Health News:Research at the cutting edge of knowledge 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 3Health News:Low radiation scans help identify cancer in earliest stages 2Health News:Low radiation scans help identify cancer in earliest stages 3
(Date:5/21/2013)... May 21, 2013  NxStage Medical, Inc. (Nasdaq: ... products, today announced that it has entered into new ... in-center products to DaVita, the kidney care division of ... ) For the use of products for ... , NxStage has executed a second amended and restated ...
(Date:5/21/2013)... New data released today at the ... that the NeuroStar TMS Therapy System ® ... in patients with Major Depressive Disorder (MDD) during ... through one year of treatment.  At the end ... symptomatic improvement while 41 percent reported complete remission. ...
(Date:5/21/2013)... Quebec , May 21, 2013 ... (NYSE: VRX ) (TSX: ... ten directors nominated at its 2013 ... detailed results of the vote for ... out below:  NameForWithheldRonald H. Farmer235,731,9341,964,748Robert A. ...
Breaking Medicine Technology:NxStage Announces New Agreements with DaVita 2New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 2New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 3New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 4Valeant Pharmaceuticals Announces 2013 Annual Meeting Results 2
Cached News: